Overall, response to multiple checkpoint and myeloid blockades is driven by both CD4 and CD8 T cells, including T cells expressing TCF, ICOS, PD-1 and KI67, as well as neutrophils and MHC+ macrophages, and MHC expression by tumor cells. The gene discussed is CD8A; the disease is neoplasm.